Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
10/09/2025
Apple: iPhone 17 Pro starting price is $1099.
Latest
2 m ago
Global aluminum market is shifting: facing shortage in 2026, prices aiming for $3000 per ton!
3 m ago
Jiaxin Wealth Management: "25 basis points" is "most favorable" for financial assets, significant interest rate cuts may cause panic.
3 m ago
Every AI Express, Shanxi Securities released a research report on September 9, giving Yonggui Electric (300351.SZ) a "buy" rating. The main reasons for the rating include: 1) 25H1 increase in revenue but not in profit, continuing to reduce costs and increase efficiency; 2) continuous breakthrough in high-power charging technology for new energy vehicles; 3) forward-looking layout in emerging areas to cultivate future growth points. (Daily Economic News)
4 m ago
According to a report released by Shanxi Securities on September 9th, Shanxi Coal International (600546.SH) has been given a "buy" rating. The main reasons for the rating include: 1) increased production, with improvements in coal production and sales in the second quarter; 2) a commitment to high dividends, with dividend value expected in the future. (Daily Economic News)
4 m ago
According to AI Express, China Post Securities released a research report on September 9 giving Jiangsu Hengrui Medicine Co., Ltd. (600276.SH) a "buy" rating. The reasons for the rating mainly include: 1) The license revenue in the first half of 2025 reached 1.99 billion yuan, with steady growth in innovative drugs; 2) The research and development of oncology and chronic disease immunotherapy are progressing simultaneously, and the employee stock ownership plan clearly outlines the future output plan for innovative drugs. (Daily Economic News)
See all latest
